Status | Study |
Completed |
Study Name: A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Skin Pruritus Condition: Skin Pruritus Date: 2015-09-30 Interventions: Drug: PAC-14028 cream 0.1% Top |
Completed |
Study Name: Safety and Pharmacokinetics of IV CR845 in Hemodialysis Patients, and Its Efficacy in Patients With Uremic Pruritus Condition: Pruritus Uremic Pruritus Date: 2014-08-27 Interventions: Drug: Part A: Placebo Part A: |
Completed |
Study Name: Open Label Extension Study of Nalbuphine HCl ER in Hemodialysis Patients With Uremic Pruritus Condition: Uremic Pruritus Pruritus Date: 2014-05-19 Interventions: Drug: nalbuphine HCl ER 60mg BID |
Completed |
Study Name: Study of Nalbuphine HCl ER Tablets in Hemodialysis Patients With Uremic Pruritus Condition: Uremic Pruritus Pruritus Date: 2014-05-17 Interventions: Drug: nalbuphine HCl ER tablets 60 mg BID |
Completed |
Study Name: Evaluation of the Antipruritic Effect of PAC-14028 Cream in Skin Pruritus Condition: Skin Pruritus Date: 2014-01-31 Interventions: Drug: PAC-14028 Participants r |
Completed |
Study Name: Study of Itch Control by VLY-686 in Healthy Volunteers After Intradermal Injections of Substance P Condition: Pruritus Date: 2013-08-02 Interventions: Drug: VLY-686 capsules contain |
Completed |
Study Name: VPD-737 for Treatment of Chronic Pruritus Condition: Chronic Pruritus Date: 2013-07-19 Interventions: Drug: VPD-737 NK1 Receptor Ant |
Withdrawn |
Study Name: Pregabalin for the Treatment of Uremic Pruritus Condition: Uremic Pruritus Date: 2013-05-08 Interventions: Drug: pregabalin 75mg daily for 12 weeks |
Recruiting |
Study Name: Study of Using Long Acting Antihistamine to Treat Opioid Induced Itching Condition: Pruritus Date: 2013-03-28 Interventions: Drug: Cetirizine Drug: Placebo or sugar pi |
Withdrawn |
Study Name: Impact of Vorinostat on Pruritus Signaling Pathways - Merck Study Condition: Pruritus Date: 2013-02-25 Interventions: Procedure: Biopsy Two 6 mm ski |